Acadia Healthcare (NASDAQ:ACHC) Sets New 1-Year Low on Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) shares hit a new 52-week low during mid-day trading on Friday after Royal Bank of Canada lowered their price target on the stock from $64.00 to $43.00. Royal Bank of Canada currently has an outperform rating on the stock. Acadia Healthcare traded as low as $31.64 and last traded at $31.96, with a volume of 911368 shares traded. The stock had previously closed at $40.26.

Other equities analysts have also recently issued research reports about the stock. TD Cowen decreased their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Bank of America decreased their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday. Barclays downgraded Acadia Healthcare from an "overweight" rating to an "equal weight" rating and cut their price target for the stock from $43.00 to $35.00 in a report on Friday. StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Finally, KeyCorp cut their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research note on Monday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $56.31.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in ACHC. Lindbrook Capital LLC increased its stake in Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after purchasing an additional 671 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after buying an additional 345 shares in the last quarter. Nisa Investment Advisors LLC grew its position in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares during the last quarter. Signaturefd LLC raised its stake in Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after acquiring an additional 1,004 shares in the last quarter. Finally, Fifth Third Bancorp lifted its position in Acadia Healthcare by 56.0% in the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after acquiring an additional 454 shares during the last quarter.

Acadia Healthcare Stock Up 4.1 %

The firm's 50 day simple moving average is $41.93 and its 200-day simple moving average is $51.32. The company has a market cap of $2.83 billion, a price-to-earnings ratio of 9.99, a P/E/G ratio of 1.46 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.